RHEUMATOLOGY101.Com

* Muscles, Bones, Joints, and Disorders

* Arthritis, Gout, Lupus, Fibromyalgia

* Find Rheumatologists by State

* News, Info, Resources

Filter= Rheumatology

 

  Exact Time

 

AI artificial intelligence being used on this site.  AI powered website.

 

* NEW GOOGLE SEARCH:

         

Custom Search

* NEW EBAY SEARCH:

 

     Like us:     Follow us:  

   

 

* Go To Z101.COM *

             


 

 

 

    

* Internet Search Results 

  *** Search Filter: "Rheumatology"

  

217 Improvementsin remission and low disease activity are achieved with ...
217 Improvementsin remission and low disease activity are achieved with ongoing sarilumabtreatment, in patients with rheumatoid arthritis in two phase III studies

Rheumatology | Oxford Academic
The official journal of the British Society for Rheumatology. Publishes high-quality scientific (basic and translational) and clinical-epidemiological papers on a wide range of paediatric and adult rheumatological and musculoskeletal conditions.

2025 British Society for Rheumatology management recommendations for ...
Abstract ANCA-associated vasculitis (AAV) is comprised of three specific conditions: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). Since the publication of the last British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guideline for the management of adults with AAV in ...

T follicular helper cells, interleukin-21 and systemic lupus ...
Abstract. SLE is a chronic systemic autoimmune disease characterized by a breakdown of tolerance to nuclear antigens and generation of high-affinity pathog

new autoantibody to valyl transfer RNA synthetase associated with anti ...
Dear Editor, The aminoacyl tRNA synthetase (ARS) antibody is the most frequently detected myositis-specific autoantibody in idiopathic inflammatory myopath

223 Sustained response in a phase III study of sarilumab plus ...
223 Sustained response in a phase III study of sarilumab plus nonbiologic disease modifying anti-rheumatic drugs in patients with active, moderate-to-severe rheumatoid arthritis and inadequate response or intolerance to tumor necrosis factor inhibitors

081 Long-term safety with sarilumab plus conventional synthetic disease ...
081 Long-term safety with sarilumab plus conventional synthetic disease-modifying antirheumatic drugs and sarilumab monotherapy in rheumatoid arthritis: an integrated analysis with 9,000 patient-years of follow-up

MUC5B - Oxford Academic
Department of Medicine, Division of Rheumatology, Corporal Michael J. Crescenz VA Medical Center and University of Pennsylvania

Volume 64 Issue 9 | Rheumatology | Oxford Academic
The official journal of the British Society for Rheumatology. Publishes high-quality scientific (basic and translational) and clinical-epidemiological papers on a wide range of paediatric and adult rheumatological and musculoskeletal conditions.

Colchicine: the good, the bad, the ugly and how to minimize the risks
Abstract Colchicine has an important role in managing various conditions, including gout, familial Mediterranean fever, amyloidosis, Behçet’s syndrome, recurrent pericarditis and calcium pyrophosphate deposition disease. The adverse effect profile of colchicine is well understood. However, due to its narrow therapeutic index, colchicine has been associated with overdose and fatalities. When ...

 

 

 

* Latest Rheumatology News

       *** News Filter: "Rheumatology"

 

 

 

 

RHEUMATOLOGY101.COM --- Rheumatology News, Rheumatology Information, Find a Rheumatologist by State, Rheumatology Resources, Lots More

Need to Find information on any subject? ASK THE RHEUMATOLOGY101 GURU and click the BIG GREEN Button above!

 * Contact us:  support@z101.com
 
                                  

Copyright 2008-2024  RHEUMATOLOGY101.COM